Atypical Fibroxanthoma — SCE Dermatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Pleomorphic dermal sarcoma because tumour invasion extends into subcutis
Explanation lettering: D = shown as A · C = shown as B · A = shown as C · B = shown as D
B is correct. AFX is a diagnosis of exclusion for a superficial pleomorphic tumour confined to dermis. Invasion into subcutaneous tissue, tumour necrosis, lymphovascular or perineural invasion supports pleomorphic dermal sarcoma, which has greater recurrence and metastatic potential and requires wider oncological planning. Negative lineage markers help exclude spindle cSCC, melanoma, leiomyosarcoma and angiosarcoma but do not by themselves establish AFX. DFSP is usually a more monomorphic CD34-positive storiform tumour with honeycomb fat infiltration rather than marked pleomorphism and necrosis.
Reference: Primary Care Dermatology Society: atypical fibroxanthoma: https://www.pcds.org.uk/clinical-guidance/atypical-fibroxanthoma